Novel blue-phosphorescent iridium complexes bearing 1-(2-pyridyl)-3-(N-methylimidazol-2-yl)-4,6-difluorobenzene(LH) as an asymmetric tridentate ligand have been optically resolved into a pair of enantiomers that exhibits opposite circularly polarized luminescence (CPL) spectra.
No takes yet. Share an insight, caveat, or question.
Ashizawa et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: